• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Spain Diabetes Care Devices Market Analysis and Forecasts to 2015 - Product Image

Spain Diabetes Care Devices Market Analysis and Forecasts to 2015

  • Published: August 2009
  • Region: Spain
  • 120 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Novo Nordisk A/S
  • Smiths Medical
  • MORE

Spain Diabetes Care Devices Market Analysis and Forecasts to 2015

Summary

Our medical device report: “Spain Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Spain diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the Spain diabetes care devices market to 2015.
- Market segmentation by glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of READ MORE >

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Executive Summary
4 Definitions of Markets Covered in the Report
4.1 Diabetes Care Devices
4.2 Glucose Monitoring Devices
4.2.1 Blood Glucose Meters
4.2.2 Blood Glucose Strips
4.3 Insulin Delivery
4.3.1 Insulin Pens
4.3.2 Insulin Syringes
4.3.3 Insulin Pumps
4.3.4 Traditional Insulin Pump Accessories
5 Healthcare Sector Review
5.1 Healthcare Expenditure
5.2 Healthcare Infrastructure
5.3 Healthcare Policy
6 Regulation System
6.1 Medical Equipment Approval Process
6.1.1 Classification of medical devices
6.1.2 Conformity Assessment Process
6.2 Post Market Surveillance (PMS)
7 Pricing and Reimbursement
7.1 Pricing and Reimbursement Policies
8 Distribution Structure
9 Diabetes Care Devices In Spain
9.1 Diabetes Care Devices, Spain, Overall Revenue ($m), 2000-2015
9.2 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015
9.3 Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015
9.4 Diabetes Care Devices, Spain, Company Share (2007-2008)
10 Glucose Monitoring In Spain
10.1 Glucose Monitoring Overall Revenue (2000-2015)
10.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
10.2 Glucose Monitoring Overall Volume (2000-2015)
10.2.1 Blood Glucose Meters Overall Volume (2000-2015)
10.3 Glucose Monitoring, Spain, Cross-Segment Analysis, 2000-2015
10.4 Glucose Monitoring Average Price (2000-2015)
10.5 Glucose Monitoring Market Dynamics
10.5.1 Market Drivers
10.5.2 Market Restraints
10.6 Glucose Monitoring Distribution Share (2007-2008)
10.7 Glucose Monitoring, Spain, Company Share (2007-2008)
11 Insulin Delivery In Spain
11.1 Insulin Delivery Overall Revenue (2000-2015)
11.1.1 Insulin Pens Overall Revenue (2000-2015)
11.2 Insulin Delivery Overall Volume (2000-2015)
11.2.1 Insulin Pens Overall Volume (2000-2015)
11.3 Insulin Delivery, Spain, Cross-Segment Analysis, 2000-2015
11.4 Insulin Delivery Average Price (2000-2015)
11.5 Insulin Delivery Market Dynamics
11.6 Insulin Delivery Distribution Share (2007-2008)
11.7 Insulin Delivery, Spain, Company Share (2007-2008)
12 Overview of Key Companies in Spain Diabetes Care Devices Market
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 Company Overview
12.1.2 Value Chain Analysis
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
12.2 LifeScan, Inc.
12.2.1 Company Overview
12.2.2 LifeScan, Inc. Pipeline Products
12.3 Bayer HealthCare AG
12.3.1 Company Overview
12.3.2 Value Chain Analysis
12.3.3 Bayer HealthCare AG Pipeline Products
12.4 Abbott Laboratories
12.4.1 Company Overview
12.4.2 Value Chain Analysis
12.4.3 Abbott Laboratories Pipeline Products
12.5 Becton, Dickinson and Company
12.5.1 Company Overview
12.5.2 Value Chain Analysis
12.6 Novo Nordisk A/S
12.6.1 Company Overview
12.6.2 Novo Nordisk A/S Pipeline Products
12.7 Eli Lilly and Company
12.7.1 Company Overview
12.7.2 Value Chain Analysis
12.7.3 Eli Lilly and Company Pipeline Products
12.8 Medtronic, Inc.
12.8.1 Company Overview
12.8.2 Value Chain Analysis
12.8.3 Medtronic, Inc. Pipeline Products
12.9 ARKRAY, Inc.
12.9.1 Company Overview
12.9.2 ARKRAY, Inc. Pipeline Products
12.10 Terumo Corporation
12.10.1 Company Overview
12.10.2 Value Chain Analysis
12.11 Animas Corporation
12.11.1 Company Overview
12.12 Sanofi-Aventis
12.12.1 Company Overview
12.13 Smiths Medical
12.13.1 Company Overview
12.13.2 Value Chain Analysis
13 APPENDIX
13.1 Research Methodology
13.2 Coverage
13.3 Secondary Research
13.4 Primary Research
13.5 Models
13.6 Forecasts
13.7 Expert Panel Validation
13.8 Currency Conversion
13.9 Contact Us
13.10 Disclaimer

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Bayer HealthCare AG
Abbott Laboratories
Becton, Dickinson and Company
Novo Nordisk A/S
Eli Lilly and Company
Medtronic, Inc.
ARKRAY, Inc.
Terumo Corporation
Animas Corporation
Sanofi-Aventis
Smiths Medical

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos